This list is based on the watchlists of people on Stock Events who follow R5XA.F. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Show more...
FAQ
What is Talphera stock price today?▼
The current price of R5XA.F is €0.68 EUR — it has increased by +3.03% in the past 24 hours. Watch Talphera stock price performance more closely on the chart.
What is Talphera stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Talphera stocks are traded under the ticker R5XA.F.
Is Talphera stock price growing?▼
R5XA.F stock has risen by +4.45% compared to the previous week, the month change is a -9.93% fall, over the last year Talphera has showed a +58.51% increase.
What is Talphera market cap?▼
Today Talphera has the market capitalization of 31.69M
When is the next Talphera earnings date?▼
Talphera is going to release the next earnings report on May 18, 2026.
What were Talphera earnings last quarter?▼
R5XA.F earnings for the last quarter are -0.05 EUR per share, whereas the estimation was -0.06 EUR resulting in a +20% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Talphera revenue for the last year?▼
Talphera revenue for the last year amounts to 0 EUR.
What is Talphera net income for the last year?▼
R5XA.F net income for the last year is -24.62M EUR.
How many employees does Talphera have?▼
As of April 12, 2026, the company has 12 employees.
In which sector is Talphera located?▼
Talphera operates in the Health & Wellness sector.
When did Talphera complete a stock split?▼
The last stock split for Talphera was on October 26, 2022 with a ratio of 1:20.
Where is Talphera headquartered?▼
Talphera is headquartered in San Mateo, Germany.